BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients - Wikidata - wikimedia - TriplyDB

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

http://www.wikidata.org/entity/Q37109755

about

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.A panel of four genes accurately differentiates benign from malignant thyroid nodules.Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher.Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.A six-genotype genetic prognostic model for papillary thyroid cancer.Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer.NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer.Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations.Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.Genetic landscape of papillary thyroid carcinoma in the Chinese population.Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.Telomere Maintenance Mechanisms in Cancer.

P2860

Q26739925-F96DD317-E4F9-4A74-992F-B2BF9F23B77B Q33685745-052D07C5-87AF-4A40-BA59-6FF898070B0B Q36221232-D8BCA8A7-9A59-4F79-B937-98B8A038ED2C Q37374678-DC0E8587-5333-4A62-AC2F-029F415F62BF Q37514988-0281FFC3-6C54-4C57-9CF0-0C1F5AB4CF87 Q37616588-90269176-D784-4307-A54D-837B5A76E096 Q38787337-8FE9C7A1-49AE-41F5-B2A7-8DB78FD01AAA Q39163637-657863C7-7B90-45E7-8D25-C605B93BD19E Q39407370-55B3E8A5-0742-46A0-815C-B27049ACEE49 Q40354589-DD8EBB6F-1C0E-4B29-902C-820EE25DF8F2 Q41091965-64FF7F70-6A99-44B0-8091-16EA31E0EF89 Q42014310-078A0B87-5F87-45A8-80B0-A4570BC34F19 Q47158539-A04D40AD-2CF1-42F2-9E5E-C1905A2D5A36 Q47185839-504B166C-78E5-4945-BA31-0A3A0D7DF79D Q47916891-976278F0-5068-499B-BFF1-3CAF8FDA796D Q48291446-0020F231-B69C-4B05-B555-F6EF00652794 Q55436824-D54E62FE-F6DD-49DD-B5A5-F0FB0A9955E0 Q55443450-9EC73974-1D9F-47DC-85DF-D64C5DA29D94

P2860

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

http://www.wikidata.org/entity/Q37109755

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

BRAF and TERT promoter mutatio ...... inoma: a study of 653 patients

@en

BRAF and TERT promoter mutatio ...... noma: a study of 653 patients.

@nl

type

label

BRAF and TERT promoter mutatio ...... inoma: a study of 653 patients

@en

BRAF and TERT promoter mutatio ...... noma: a study of 653 patients.

@nl

prefLabel

BRAF and TERT promoter mutatio ...... inoma: a study of 653 patients

@en

BRAF and TERT promoter mutatio ...... noma: a study of 653 patients.

@nl

P1433

Q37109755-0944B3F8-B488-4CB3-8261-AE06900FA428

P1476

Q37109755-41DC23F7-2426-4CCC-B8BB-08DDB5CDEBD4

P2093

Q37109755-04BD8DE2-DB8D-49A3-878C-AA7062789793

Q37109755-08611A96-98B9-46AD-AA9B-300565B79F98

Q37109755-2F15ABA5-DCE9-498B-8342-F0B3EC6E6B22

Q37109755-45B5263D-6A54-49A9-94DE-EE0A0B400F1B

Q37109755-5BDE553A-A6A0-4AAB-BD4E-D8AB6064935C

Q37109755-685F39AC-4B00-45F3-BB88-73AB27F29784

Q37109755-7AE8640E-681B-4CB6-AEC6-632CC915CC4D

Q37109755-7BA00BAA-C00E-433C-BCC8-E3EB5D8CC88C

Q37109755-7BFD5DBD-5E37-48DF-A8FA-EF43CB1B6776

Q37109755-9A5AA3BF-C6AB-484A-B00C-D95D78D2B34D

P2860

Q37109755-05261DDC-4F8E-4E79-B1FD-740DC0626C2D

Q37109755-14C12D7F-893F-459F-87EF-8DB5266E452B

Q37109755-17DE9A42-F55B-4860-81FB-618EB0F48711

Q37109755-1A2EB4DC-D398-4689-9ECE-1F7EB4F86BDF

Q37109755-1BA50D5E-D5D4-49F3-A043-121AF1BE5577

Q37109755-1CEFE56F-201E-4139-B7F3-3A9DDF9AF074

Q37109755-219B71C5-9493-41B2-A855-AB30ED32FEFE

Q37109755-33D5811F-DC8B-4C6E-9D15-34B1EA1C7990

Q37109755-47CC3FBC-06D6-495A-AC65-4745D3929884

Q37109755-4E7EAAD8-AE6C-4C2C-BD26-1292CF45588E

P304

Q37109755-83254A23-369A-4607-8BD3-9816417B1637

P31

Q37109755-051D73FC-3AA3-497E-B58F-E217C696B1F8

P356

Q37109755-1B567E72-BA8A-405D-A09D-7014C8A341AD

P407

Q37109755-9A6FA7B7-FEA2-4BA1-8973-8C77A3FEE466

P433

Q37109755-6E3A7C68-4F2C-4F27-9499-B28AA55E62F9

P478

Q37109755-A2DB5748-223F-4A3F-99B0-9811352E38BD

P577

Q37109755-CF93D93C-1C59-44EB-BCF6-2B0101280F53

P698

Q37109755-76846D23-A51C-401C-96A6-A50A1B0D75E4

P921

Q37109755-ABBDE448-F004-4BD5-9663-8720F783BCD7

P932

Q37109755-122B9690-E69C-4D23-92F4-BCE00E9C1CA6

P356

ONCOTARGET.7811

P1433

P1476

BRAF and TERT promoter mutatio ...... inoma: a study of 653 patients

@en

P2093

Chuanmeng Pan

http://www.w3.org/2001/XMLSchema#string

Endong Chen

http://www.w3.org/2001/XMLSchema#string

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Langping Jin

http://www.w3.org/2001/XMLSchema#string

Mingzhao Xing

http://www.w3.org/2001/XMLSchema#string

Ouchen Wang

http://www.w3.org/2001/XMLSchema#string

Ruichao Zeng

http://www.w3.org/2001/XMLSchema#string

Siyang Dong

http://www.w3.org/2001/XMLSchema#string

Weili Wu

http://www.w3.org/2001/XMLSchema#string

Xiangjian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

Integrated genomic characterization of papillary thyroid carcinoma

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

Highly recurrent TERT promoter mutations in human melanoma

TERT promoter mutations in familial and sporadic melanoma

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

P304

18346-18355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7811

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26943032

http://www.w3.org/2001/XMLSchema#string

P921

P932

4951292

http://www.w3.org/2001/XMLSchema#string